Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000547038 | SCV000658246 | likely benign | DICER1-related tumor predisposition | 2025-01-19 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000567535 | SCV000661962 | uncertain significance | Hereditary cancer-predisposing syndrome | 2023-08-04 | criteria provided, single submitter | clinical testing | The p.K1241R variant (also known as c.3722A>G), located in coding exon 20 of the DICER1 gene, results from an A to G substitution at nucleotide position 3722. The lysine at codon 1241 is replaced by arginine, an amino acid with highly similar properties. This amino acid position is well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Fulgent Genetics, |
RCV000765195 | SCV000896430 | uncertain significance | Euthyroid goiter; Rhabdomyosarcoma, embryonal, 2; DICER1-related tumor predisposition | 2018-10-31 | criteria provided, single submitter | clinical testing | |
Gene |
RCV003317278 | SCV004021628 | uncertain significance | not provided | 2023-07-07 | criteria provided, single submitter | clinical testing | Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |